Showing results (21-30 of 100) with videos related to

Sort By:
Pageof 10
The Lancet Regional Health. Western Pacific|July 30, 2021
Trends in kidney failure and kidney replacement therapy in people with diabetes in Hong Kong, 2002-2015: A retrospective cohort studyHongjiang Wu, Eric S H Lau, Aimin Yang, et al.
The Lancet Regional Health. Western Pacific|July 5, 2022
Glucose-lowering drug use, glycemic outcomes, and severe hypoglycemia: 18-Year trends in 0·9 million adults with Diabetes in Hong Kong (2002-2019)Aimin Yang, Hongjiang Wu, Eric S H Lau, et al.
Cardiovascular Diabetology|January 29, 2026
Age-specific associations between blood pressure and cardiovascular disease, kidney disease, and death among individuals with type 2 diabetes: a population-based cohort studyEdith W K Chow, Yingnan Fan, Hongjiang Wu, et al.
Diabetologia|June 5, 2026
Early glycaemic exposure and cancer risk in people with newly diagnosed type 2 diabetesXinge Zhang, Aimin Yang, Hongjiang Wu, et al.
Diabetes Care|November 18, 2025
Young-Onset Hypertension Confers Higher Risk of Cardiovascular Disease, Kidney Disease, and All-Cause Mortality in Individuals With Type 2 Diabetes: A Propensity Score-Matched Cohort AnalysisEdith W K Chow, Yingnan Fan, Hongjiang Wu, et al.
Eclinicalmedicine|December 2, 2022
Clinical outcomes following discontinuation of renin-angiotensin-system inhibitors in patients with type 2 diabetes and advanced chronic kidney disease: A prospective cohort studyAimin Yang, Mai Shi, Eric S H Lau, et al.
The Lancet Regional Health. Western Pacific|November 24, 2022
The role of age on the risk relationship between prediabetes and major morbidities and mortality: Analysis of the Hong Kong diabetes surveillance database of 2 million Chinese adultsXinge Zhang, Hongjiang Wu, Baoqi Fan, et al.
Diabetes, Obesity & Metabolism|May 28, 2024
Association of dipeptidyl peptidase-4 inhibitor initiation at glycated haemoglobin <7.5% with reduced major clinical events mediated by low glycated haemoglobin variabilityJohnny T K Cheung, Aimin Yang, Hongjiang Wu, et al.
Diabetes Research and Clinical Practice|December 9, 2022
Initiation of sodium-glucose cotransporter-2 inhibitors at lower HbA1c threshold attenuates eGFR decline in type 2 diabetes patients with and without cardiorenal disease: A propensity-matched cohort studyJohnny T K Cheung, Aimin Yang, Hongjiang Wu, et al.
Plos Medicine|July 21, 2022
Lifetime risk of developing diabetes in Chinese people with normoglycemia or prediabetes: A modeling studyXinge Zhang, Hongjiang Wu, Baoqi Fan, et al.
Pageof 10